EXIT071 is a Netherlands-based startup developing advanced technologies for extracellular vesicle (EV) isolation and analysis.
EXIT071 has raised $2.1M in total funding. The most recent round was Seed. The last funding was announced in March 2025.
EXIT071's investors include Biotech Booster, UNIIQ, LEH.
EXIT071 is headquartered in Leiden, The Netherlands.
EXIT071 is a Netherlands-based startup developing advanced technologies for extracellular vesicle (EV) isolation and analysis.
EXIT071 is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"EXIT071 — Funding & Investors." VCBacked, March 24, 2025, https://www.vcbacked.co/company/exit071. Accessed November 15, 2026.
VCBacked. (2025). EXIT071 — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/exit071
{{cite web |title=EXIT071 — Funding & Investors |url=https://www.vcbacked.co/company/exit071 |website=VCBacked |access-date=November 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at EXIT071? Request a listing update